{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:21:10Z","timestamp":1794277270059,"version":"4.9.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-123490"],"award-info":[{"award-number":["MOP-123490"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["HSFC G-17-0019 106"],"award-info":[{"award-number":["HSFC G-17-0019 106"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.atherosclerosis.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T11:06:56Z","timestamp":1679915216000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Stimulation of soluble guanylate cyclase activity with riociguat promotes angiogenesis and improves neovascularization after limb ischemia"],"prefix":"10.1016","volume":"372","author":[{"given":"Wahiba","family":"Dhahri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Dussault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozha","family":"Raguema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Desjarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1161\/01.CIR.0000128595.79378.FA","article-title":"Therapeutic angiogenesis and vasculogenesis for ischemic disease: part I: angiogenic cytokines","volume":"109","author":"Losordo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.115.303565","article-title":"Modulating the vascular response to limb ischemia: angiogenic and cell therapies","volume":"116","author":"Cooke","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.ph.49.030187.002321","article-title":"Mechanisms of angiogenesis","volume":"49","author":"D'Amore","year":"1987","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib6","first-page":"10","article-title":"Circulating and tissue resident endothelial progenitor cells","volume":"229","author":"Basile","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib7","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1172\/JCI119868","article-title":"Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells","volume":"100","author":"Papapetropoulos","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib8","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.041359198","article-title":"Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability","volume":"98","author":"Fukumura","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib9","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1172\/JCI1560","article-title":"Nitric oxide synthase modulates angiogenesis in response to tissue ischemia","volume":"101","author":"Murohara","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib10","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm948","article-title":"Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells","volume":"9","author":"Aicher","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib11","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.atherosclerosis.2015.06.010","article-title":"Psychological stress impairs ischemia-induced neovascularization: protective effect of fluoxetine","volume":"241","author":"Maingrette","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib16","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","article-title":"Nitric oxide signalling in cardiovascular health and disease","volume":"15","author":"Farah","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.niox.2018.04.011","article-title":"Physiological activation and deactivation of soluble guanylate cyclase","volume":"77","author":"Horst","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1515\/hsz-2018-0155","article-title":"From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators","volume":"399","author":"Sandner","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","article-title":"Soluble guanylate cyclase: a potential therapeutic target for heart failure","volume":"18","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042623","article-title":"Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade","volume":"7","author":"Ott","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083910","article-title":"Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI\/PET imaging","volume":"8","author":"Methner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib26","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1038\/ncomms8235","article-title":"Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue","volume":"6","author":"Hoffmann","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1124\/jpet.106.108878","article-title":"Soluble guanylyl cyclase activation promotes angiogenesis","volume":"319","author":"Pyriochou","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.20929","article-title":"The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G\/MAPK pathway","volume":"211","author":"Pyriochou","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib29","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/ATVBAHA.107.147421","article-title":"Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway","volume":"27","author":"Senthilkumar","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vph.2010.08.004","article-title":"PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesis","volume":"53","author":"Koika","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib31","doi-asserted-by":"crossref","first-page":"34301","DOI":"10.1074\/jbc.274.48.34301","article-title":"Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells","volume":"274","author":"Komalavilas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2019.07.017","article-title":"Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension","volume":"299","author":"Yamamoto","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/HYPERTENSIONAHA.109.139451","article-title":"Sildenafil increases endothelial progenitor cell function and improves ischemia-induced neovascularization in hypercholesterolemic apolipoprotein E-deficient mice","volume":"54","author":"Dussault","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2023.03.017_bib34","doi-asserted-by":"crossref","first-page":"e4879","DOI":"10.1371\/journal.pone.0004879","article-title":"cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis","volume":"4","author":"Aicher","year":"2009","journal-title":"PLoS One"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:51:22Z","timestamp":1758156682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"alternative-id":["S0021915023001193"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.03.017","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulation of soluble guanylate cyclase activity with riociguat promotes angiogenesis and improves neovascularization after limb ischemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}